Entamoeba histolytica/Entamoeba dispar infections in human immunodeficiency virus-infected patients in the United States

Citation
Sa. Lowther et al., Entamoeba histolytica/Entamoeba dispar infections in human immunodeficiency virus-infected patients in the United States, CLIN INF D, 30(6), 2000, pp. 955-959
Citations number
20
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
30
Issue
6
Year of publication
2000
Pages
955 - 959
Database
ISI
SICI code
1058-4838(200006)30:6<955:EHDIIH>2.0.ZU;2-T
Abstract
We describe the incidence of and laboratory and clinical characteristics as sociated with Entamoeba histolytica/Entamoeba dispar infection diagnosed in human immunodeficiency virus (HIV-infected persons enrolled in the Adult a nd Adolescent Spectrum of HIV Disease Project, From 1 January 1990 to 1 Jan uary 1998 (82,518 person-years of follow-up), 111 patients (98% men) were d iagnosed with E. histolytica/E. dispar infection. Among HIV-infected patien ts in the United States, the incidence of diagnosed E. histolytica disease is low (13.5 cases per 10,000 person-years [95% confidence interval, 7.7-22 .2], with diagnosis most common in those patients exposed to HIV through ma le-male sex.